Rheumatoid arthritis (RA) is a disease characterized by the chronic inflammation of joint synovial tissues. Inflammatory synovial tissue is called pannus. At such sites, many newly formed vessels are observed [1] [2] [3] . Angiogenic factors such as vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang-1), and angiopoietin-2 (Ang-2) play important roles in the angiogenesis of pannus 3 .
VEGF is particularly important 4 . It promotes angiogenesis by acting on vascular endothelial cells and promoting endothelial cell migration and lumen formation 5 . In patients with RA, VEGF is detected in joints and serum, and is considered to be closely related to the development of pathologic features of arthritis and especially angiogenesis [6] [7] [8] . Ang-1 and Ang-2 contribute to adhesion and detachment between vascular endothelial and wall cells 9 . Ang-1 is constantly secreted from wall cells when blood vessels are stable. Ang-1 is bound to Tie2 on endothelial cells, and this binding is related to the binding between vascular endothelial and wall cells. But the detachment of vascular endothelial and wall cells is necessary for the initiation of angiogenesis. At their detachment, Ang-2, an endogenous antagonist molecule highly homologous to Ang-1, is secreted by vascular endothelial cells and induces the inactivation of Tie2 by inhibiting the binding between Ang-1 and Tie2. As a result, the adhesion between vascular endothelial and wall cells is inhibited, and angiogenesis is initiated. In this state, Ang-2 is dominant over Ang-1. Once new vessels have been formed, their stabilization becomes important. Adhesion between vascular endothelial and wall cells becomes necessary again to stabilize the newly formed vessels. Therefore,
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The Journal on August 14, 2017 -Published by www.jrheum.org Downloaded from Ang-1 is secreted again by wall cells and binds with Tie2 on endothelial cells. In this state, Ang-1 is dominant over Ang-2 [10] [11] [12] [13] [14] .
Experiments using synovial tissues from patients with RA have confirmed the roles of Ang-1 and Ang-2 in angiogenesis [15] [16] [17] . Both have been observed to be important but to act in different periods. Ang-1 has been observed to be important for the maintenance of blood vessels, and Ang-2 to play a role at sites of marked angiogenesis.
While VEGF, Ang-1, and Ang-2 are connected to angiogenesis in synovial regions, the clinical significance of their levels in serum is unclear. The serum level of VEGF has been observed to serve as an index of the severity of joint destruction in RA, but there have been few studies concerning the levels of serum Ang-1 or Ang-2. One study said that the serum Ang-1 level was correlated with the erythrocyte sedimentation rate 8 . In addition, there has been no research on simultaneous measurement of serum levels of VEGF, Ang-1, and Ang-2, with evaluation of their relationships. In our study, therefore, we simultaneously measured the serum levels of these 3 factors in patients with RA and evaluated their relationships with indices of RA activity.
MATERIALS AND METHODS
The subjects were 70 patients (55 women and 15 men) with RA who fulfilled the diagnostic criteria of the American College of Rheumatology (1987) 18 . The mean age of the subjects was 56.2 ± 13.5 (range 24-85) years. The study was approved by the Ethical Committee of Jikei University School of Medicine in advance. Informed consent was obtained from all patients.
Measurement of serum levels of angiogenic factors. The serum samples were stored at -40˚C, and measurements were performed within 3 months after collection. Serum VEGF, Ang-1, and Ang-2 levels were determined using an ELISA kit (R&D Systems, Minneapolis, MN, USA). The mean values of double measurements were calculated.
Ultrasonography assessment. Power Doppler ultrasonography (PDUS) was performed in the dark. Ultrasound was emitted with a linear array transducer (10 MHz; GE Healthcare, Waukesha, WI, USA). The pulse repetition frequency was set at the lowest level in the tolerated range to achieve the maximum sensitivity, 500-750 Hz. Low wall filters were used. The dynamic range was set at 20-40 dB. PDUS was performed in a total of 10 joints: the bilateral shoulders, elbows, wrists, knees, and ankles. The probe was applied to the posterior recess, biceps tendon sheath and subdeltoid bursa in the shoulder, anterior and posterior recesses in the elbow, dorsal carpal recesses, extensor tendon sheaths and flexor tendon sheaths in the wrist, suprapatellar, medial parapatellar and lateral parapatellar recesses in the knee, and anterior, medial and lateral tendon sheaths in the ankle. After PDUS, video clips recorded by 2 operators were analyzed. The clinical conditions and examination data of the analyzed patients were concealed from the analyzers. The blood flow signals at various sites of the synovial membrane were graded and scored as follows: grade 1: no flow (0 point); grade 2: mild or moderate flow (1 point); grade 3: intense flow (2 points). The score at the site with the strongest finding in each joint was adopted as the score of the joint, and the total of the scores of the 10 joints was defined as the total signal score (TSS).
Statistical analysis was performed using Graphpad Prism software (Version 4.0). The relationships of clinical data and findings on ultrasonography were analyzed using Spearman's rank correlation test. P < 0.05 was considered significant. Table 1 shows the patients' characteristics. The duration of the disease was 4.43 ± 4.81 years (mean ± SD). The duration was within 1 year after the onset in 14, 1-5 years in 29, 5-10 years in 17, and 10 years or longer in 9.
RESULTS

Patients' characteristics.
The dose of oral prednisolone was 0 mg in 29 patients, 5 mg or less in 11, 5-10 mg in 21, and 10 mg or more in 10. The dose of methotrexate was 0 mg in 33 patients, 0-4 mg in 7, 4-8 mg in 22, and 8 mg or more in 8. Biological preparations were used in 7 patients. The mean serum C-reactive protein (CRP) level was 2.166 ± 3.27 mg/dl, the mean serum matrix metalloprotease (MMP)-3 level was 1.77 ± 41 ng/ml, and mean 28-joint count Disease Activity Score (DAS28)-CRP was 3.324 ± 1.12. DAS28-CRP was 1-2 in 8 patients, 2-3 in 20, 3-4 in 26, 4-5 in 9, 5-6 in 6, and 6-7 in 1 patient. The mean serum VEGF level was 620.46 ± 567.3 pg/ml, mean serum Ang-1 level was 35,975.08 ± 11,200.65 pg/ml, and mean serum Ang-2 level was 3,377.614 ± 1,434.909 pg/ml. Serum levels of angiogenic factors and indices of disease activity. Figure 1 shows the relationships of the serum VEGF level with the serum CRP and MMP-3 levels, DAS28-CRP, and TSS. The serum VEGF level was significantly correlated with the serum CRP level (r = 0.5013, p < 0.0001), serum MMP-3 level (r = 0.3567, p = 0.0033), DAS28-CRP (r = 0.6527, p < 0.0001), and TSS (r = 0.4824, p < 0.0001). Figure 4 shows the relationships among the serum levels of angiogenic factors. A significant correlation (r = 0.3005, p = 0.0142) was noted between VEGF and Ang-1 but not between VEGF and Ang-2 (r = 0.1429, p = 0.2378) or between Ang-1 and Ang-2 (r = 0.02165, p = 0.8630).
DISCUSSION
We noted increases in the serum levels of angiogenic factors in patients with RA. These factors were correlated with at least 1 of the serum CRP level, serum MMP-3 level 19 , DAS28-CRP 20 , and TSS [21] [22] [23] , which are considered to reflect the activity of RA. These factors have been observed of Rheumatology
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The serum VEGF level was correlated with the serum CRP and MMP-3 levels, DAS28-CRP, and TSS. The serum VEGF level has been observed to be correlated with the serum CRP level 7 and DAS28 8 , but the relationship between the serum VEGF and MMP-3 levels has not been observed. The serum MMP-3 level is useful as a predictive factor for joint destruction 24 . The serum VEGF level has been observed by radiographic analysis to be an index of joint destruction 8 . Thus, as both the serum VEGF and MMP-3 levels have been observed to reflect joint destruction, their correlation may be explained from this perspective.
In addition to our 2009 study 25 , Strunk, et al 26 observed the relationship between the serum VEGF level and synovial blood flow signals. We observed that the serum VEGF level was correlated with the synovial blood flow signal level in the wrist, but Strunk, et al did not observe such a correlation. In these 2 studies, evaluation was made of the wrists alone. While the serum VEGF level is a systemic finding, the synovial blood flow signals of the wrist are local findings. Therefore, evaluation of various joints of the body was considered necessary to examine the relationship between serum VEGF level and synovial blood flow signals. So we examined multiple joints. The number of patients was also markedly increased. As a result, a correlation between the serum VEGF level and TSS could be confirmed. The increase in synovial blood flow signals has been observed histologically to be caused by an increase in the number of blood vessels in the synovial tissue, i.e., angiogenesis 27 . Thus, the correlation between the serum level of VEGF, which is a major angiogenic factor, and TSS appears reasonable.
The serum VEGF level was correlated with all 4 measures of RA activity examined in our study. Therefore, the serum VEGF level is considered useful as an index of RA activity and a predictive factor for joint destruction based on angiogenesis.
The correlations of the serum Ang-1 and Ang-2 levels with indices of RA activity were weaker than the correlations of the serum VEGF level, and their clinical significance was difficult to determine. A close examination of the data revealed a comparison between the serum Ang-1 and Ang-2 levels that was of interest. The serum Ang-1 level was correlated with the serum MMP-3 level but not with the serum CRP level. The serum Ang-2 level, on the other hand, was correlated with the serum CRP level but not with the serum MMP-3 level. While the serum MMP-3 level reflects disease activity, it is less useful than the serum CRP level as a disease activity marker. But the serum MMP-3 level correlates closely with the outcome of patients with RA, particularly the degree of radiological joint destruction. Thus, the serum MMP-3 level is an index of sustained arthritis and is useful as a predictive factor for the radiological outcome of RA. In contrast, serum CRP level is considered to be most useful as an index of disease activity on examination. The serum level of Ang-1, which is important for the maintenance of newly formed vessels, is related to indices of sustained arthritis, and the serum level of Ang-2, which is important in marked angiogenesis, is related to indices of disease activity on examination.
While DAS28-CRP was correlated with the serum Ang-1 level but not the serum Ang-2 level, the p or r value showed no marked difference, and the correlations of DAS28-CRP with the serum Ang-1 and Ang-2 levels were weaker than those of the VEGF level. Serum Ang-1 and Ang-2 levels are considered to be less sensitive indices of RA activity than the serum VEGF level.
The relationship with the TSS also differed between the serum Ang-1 and Ang-2 levels. The TSS correlated with the level of Ang-2 but not with the Ang-1 level. Synovial blood flow signals have been observed to be related to angiogenesis. It remains unclear in which period it is related more closely to angiogenesis. Since the TSS correlated with Ang-2 but not with Ang-1, synovial blood flow signals are considered to represent angiogenesis particularly in a phase of the disease showing vigorous angiogenesis. Synovial blood flow signals have been seen to fluctuate dynamically, responding to various treatments, particularly treatment with tumor necrosis factor-α inhibitors [28] [29] [30] . The data from our study may explain this.
Among the angiogenic factors we examined, a correlation was observed between the serum levels of VEGF and of Ang-1 but not in the other combinations. The absence of a correlation between the serum Ang-1 and Ang-2 levels is understandable based on other data. The correlation of VEGF level with the level of Ang-1 rather than the level of Ang-2 may indicate the usefulness of the serum VEGF level as an index of sustained arthritis.
